The definition of paradoxical psoriasis (PP) encompasses 2 main scenarios, namely, (i) new-onset psoriasis in patients treated for a different disease and (ii) worsening as well as phenotypical change of pre-existing psoriasis. Originally restricted to the appearance of an untoward psoriasiform reaction under TNF inhibitors, the term has gained new meaning, with the progressive observation of psoriasis-like eruptions also with other medications. Although the conceptual framework of PP has expanded, a molecular and clinicotherapeutic classification is still lacking. In addition, a certain degree of confusion surrounds the correct terminology to indicate these eruptions. In this paper, evidence on the epidemiology, clinical features, pathogenesis, and treatment of PP is reviewed, providing a perspective on possible pathogenesis-driven therapeutic approaches.

Paradoxical Psoriasis: An Updated Review of Clinical Features, Pathogenesis, and Treatment Options / C.A. Maronese, M. Valenti, C. Moltrasio, M. Romagnuolo, S.M. Ferrucci, M. Gilliet, A. Costanzo, A.V. Marzano. - In: JOURNAL OF INVESTIGATIVE DERMATOLOGY. - ISSN 0022-202X. - 144:11(2024), pp. 2364-2376. [10.1016/j.jid.2024.05.015]

Paradoxical Psoriasis: An Updated Review of Clinical Features, Pathogenesis, and Treatment Options

C.A. Maronese
Primo
;
M. Romagnuolo;A. Costanzo;A.V. Marzano
Ultimo
2024

Abstract

The definition of paradoxical psoriasis (PP) encompasses 2 main scenarios, namely, (i) new-onset psoriasis in patients treated for a different disease and (ii) worsening as well as phenotypical change of pre-existing psoriasis. Originally restricted to the appearance of an untoward psoriasiform reaction under TNF inhibitors, the term has gained new meaning, with the progressive observation of psoriasis-like eruptions also with other medications. Although the conceptual framework of PP has expanded, a molecular and clinicotherapeutic classification is still lacking. In addition, a certain degree of confusion surrounds the correct terminology to indicate these eruptions. In this paper, evidence on the epidemiology, clinical features, pathogenesis, and treatment of PP is reviewed, providing a perspective on possible pathogenesis-driven therapeutic approaches.
Biologics; Dupilumab; Paradoxical psoriasis; Psoriasiform reaction; TNF inhibitors
Settore MEDS-10/C - Malattie cutanee e veneree
2024
Article (author)
File in questo prodotto:
File Dimensione Formato  
PIIS0022202X24017317.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 1.57 MB
Formato Adobe PDF
1.57 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/1135155
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 21
  • ???jsp.display-item.citation.isi??? 15
  • OpenAlex ND
social impact